Global Transcatheter Aortic Valve Replacement Market Surges at 16.90% CAGR 2016-2020 due to High Incidence of Cardiovascular Diseases


Published Date : May 16, 2016

Albany, New York, May 16, 2016: MarketResearchReports.biz has recently added a new research report to its resourceful database. The research report, titled “Global Transcatheter Aortic Valve Replacement Market 2016-2020,” offers a never-seen-before perspective of the global transcatheter aortic valve replacement market. Researchers have highlighted the various trends and dynamics governing this market. According to the research report, the global transcatheter aortic valve replacement market is expected to rise at a CAGR of 16.90% from 2016 to 2020. The research report justifies this growth rate by shedding light on the market drivers and restraints in the overall market.

Transcatheter heart valve replacement systems are used in cardiovascular surgeries to fix the aortic valve. These devices help in repairing the valve without altering or removing the old and damaged valves of the heart. Transcatheter aortic valve replacement surgeries are carried out for treating aortic valve disorders such as aortic stenosis, regurgitation, and degeneration. The two ways of approaching a transcatheter aortic valve replacement are through the femoral artery, which is known as the transfemoral approach and through a chest incision, known as the transapical approach.

The global transcatheter aortic valve replacement market will be driven by the high incidence of aortic stenosis due to growing number of geriatrics across the globe. However, the market faces a tough challenge of the high risk of complications in these surgeries. Ongoing clinical trials are expected to open up newer opportunities for the global transcatheter aortic valve replacement market in the near future. Furthermore, the introduction of new transcatheter valve implants in Japan and the US will propel this market.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/527388

The research report segments the overall global transcatheter aortic valve replacement market on the basis of geography into the Americas, Asia Pacific, Europe, and the Middle East and Africa. In order to estimate the revenue that is likely to be generated by these regions, the report sheds light on the specific factors that will support the growth in specific regions along with the ones restricting it. The report also answers questions pertaining to the market size and growth rate this market will achieve by 2020. Additionally, it provides a feasibility report of the investments being pumped into in the research and development of transcatheter aortic valve replacement systems.

The key players in the global transcatheter aortic valve replacement market are St. Jude Medical, Edwards Lifesciences, Boston Scientific, Medtronic, Direct Flow Medical, Meril Life Sciences, SYMETIS, JenaValve Technology, and Sorin. The research report profiles these players and provides a complete reports of the competitive landscape of the overall market. The report also evaluates the technological developments that are expected to change the course of this market in the coming years. Furthermore, the report includes the financial overview, research and development activities, investment outlook, and strategic mergers and acquisitions of these top players for the coming few years.

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz